Post by
Golddetector on Jan 23, 2022 10:49am
QIXLEEF
We are at phaseII FDA (reborn trial) projected to conclude Q1 fda thumb up to follow shortly. Imo big pharma will take over from there. If you check most of take overs are at that stage. Tetra has to play this carefully. Sp is too low for a take over. This needs to be at least 1$ to get something meaningful to shareholders. Let's keep in mind this was above 1$ before covid and they did not advance the trials at that time. All this value added is not captured in sp. the following weeks in q1 and q2 will be interesting
Comment by
DONOOW on Jan 23, 2022 12:55pm
Pumpers are active these days, remember at 0.40 they were attacking every body saying it will reach 0.20 , don't forget